These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19149638)
21. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. Wise RA; Wigley F; Newball HH; Stevens MB Chest; 1982 Jun; 81(6):695-8. PubMed ID: 7075304 [TBL] [Abstract][Full Text] [Related]
22. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma. Freedman RR; Girgis R; Mayes MD J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897 [TBL] [Abstract][Full Text] [Related]
23. Local and central orthostatic sympathetic reflexes in Raynaud's phenomenon. Engelhart M; Kristensen JK Scand J Clin Lab Invest; 1991 Apr; 51(2):191-6. PubMed ID: 2042023 [TBL] [Abstract][Full Text] [Related]
24. Functional infrared imaging of paroxysmal ischemic events in patients with Raynaud's phenomenon. Grossi G; Mariotti A; Di Donato L; Amerio P; Tulli A; Romani GL; Merla A Int J Immunopathol Pharmacol; 2010; 23(2):627-32. PubMed ID: 20646358 [TBL] [Abstract][Full Text] [Related]
25. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon. Furspan PB; Chatterjee S; Mayes MD; Freedman RR Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304 [TBL] [Abstract][Full Text] [Related]
26. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM; Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489 [TBL] [Abstract][Full Text] [Related]
27. Recent achievements in the management of Raynaud's phenomenon. Baumhäkel M; Böhm M Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628 [TBL] [Abstract][Full Text] [Related]
33. Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis. Goodfield MJ; Rowell NR Br J Dermatol; 1988 Nov; 119(5):643-6. PubMed ID: 3207617 [TBL] [Abstract][Full Text] [Related]
34. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study. Ingegnoli F; Gualtierotti R; Pierro L; Del Turco C; Miserocchi E; Schioppo T; Meroni PL; ; Microvasc Res; 2015 Jan; 97():31-6. PubMed ID: 25262916 [TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of Raynaud's phenomenon. Herrick AL Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200 [TBL] [Abstract][Full Text] [Related]
36. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension. Wigley FM Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460 [TBL] [Abstract][Full Text] [Related]
37. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma. Freedman RR; Girgis R; Mayes MD J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511 [TBL] [Abstract][Full Text] [Related]
38. Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosis. Marasini B; Conciato L Clin Rheumatol; 2001; 20(6):451-2. PubMed ID: 11771535 [No Abstract] [Full Text] [Related]